Dihydroartemisinin Inhibited Stem Cell-Like Properties and Enhanced Oxaliplatin Sensitivity of Colorectal Cancer via AKT/mTOR Signaling

Researchers found that dihydroartemisinin (DHA) inhibited cell viability in HCT116 and SW620 cells. Moreover, DHA decreased cell clonogenicity, and improved oxaliplatin sensitivity.